GlassScriptPhysician profile
Brenton Walter Smith
NPI 1811489131
$467.90
in general payments reported to CMS, 2019-2025
12 companies · $444 in 2025
The $444 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $23.45 · 2025: $444.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $468.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $467.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $100.66 | 2025 | Ozempic, Wegovy |
| Astrazeneca Pharmaceuticals LP | $72.97 | 2025 | Breztri, Farxiga |
| Lilly USA, LLC | $56.92 | 2024-2025 | Mounjaro, Zepbound, Jardiance |
| Sumitomo Pharma America, INC. | $50.88 | 2025 | Gemtesa |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $33.18 | 2025 | Caplyta |
| Amgen INC. | $31.78 | 2025 | Otezla, Repatha |
| Dexcom, INC. | $30.04 | 2025 | Dexcom G6 Transmitter |
| Acadia Pharmaceuticals INC | $26.52 | 2025 | Daybue |
| Exact Sciences Corporation | $19.54 | 2025 | The Cologuard Plus Collection Kit |
| Glaxosmithkline, LLC. | $16.98 | 2025 | Shingrix, Arexvy |
| Collegium Pharmaceutical, INC. | $14.97 | 2025 | Jornay Pm |
| Boehringer Ingelheim Pharmaceuticals, INC. | $13.46 | 2025 | Jardiance |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brenton Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.